User profiles for Naglla Elimam
 | Naglla A ElimamPediatric oncology Verified email at ngha.med.sa Cited by 132 |
FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies
Background Outcomes of relapsed/refractory childhood acute leukemia remain poor. We
analyzed the safety/efficacy of fludarabine, cytarabine, and granulocyte colony stimulating factor…
analyzed the safety/efficacy of fludarabine, cytarabine, and granulocyte colony stimulating factor…
Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource‐rich developing country
W Jastaniah, N Elimam, K Abdalla… - Pediatric Blood & …, 2015 - Wiley Online Library
Background The outcome of children with acute lymphoblastic leukemia (ALL) in developing
countries is less favorable than in developed countries, primarily due to resource constraints…
countries is less favorable than in developed countries, primarily due to resource constraints…
[HTML][HTML] Clinical and pathological characteristics of extra-cranial germ cell tumors: A 30-year single-center experience in Saudi Arabia
…, H Ilana, H Deena, A Omaima, E Naglla - Saudi Medical …, 2023 - ncbi.nlm.nih.gov
Objectives: To investigate the clinical and pathological characteristics of extracranial germ
cell tumors (GCTs) in children aged 0–168 months treated at the National Guard Hospital, …
cell tumors (GCTs) in children aged 0–168 months treated at the National Guard Hospital, …
A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center
…, A Mukhtar, SA Khansa, N Elimam… - Journal of Oncology …, 2013 - journals.sagepub.com
Background Chemotherapy-induced nausea and vomiting are the most dreaded and distressing
side effects for cancer patients undergoing chemotherapy treatment. These side effects …
side effects for cancer patients undergoing chemotherapy treatment. These side effects …
A clinical approach to non-neutropenic fever in children with cancer
…, M AlDabbagh, N Elimam - Journal of Oncology …, 2021 - journals.sagepub.com
Background There are a limited number of studies that address non-neutropenic fever
episodes in children with cancer, and no standard approach exists. Method We opt to …
episodes in children with cancer, and no standard approach exists. Method We opt to …
[HTML][HTML] The prognostic significance of hypertension at diagnosis in children with wilms tumor
W Jastaniah, N Elimam, RS Alluhaibi… - Saudi Medical …, 2017 - ncbi.nlm.nih.gov
Objectives: To determine the prognostic effect of hypertension at diagnosis on outcomes of
children with Wilms tumor (WT). Methods: A single center retrospective analysis was …
children with Wilms tumor (WT). Methods: A single center retrospective analysis was …
[HTML][HTML] Early vs. late MRD response-and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia
Background Refinement of risk-based treatment stratification by minimal residual disease (MRD)
at different time points has improved outcomes of childhood acute lymphoblastic …
at different time points has improved outcomes of childhood acute lymphoblastic …
[HTML][HTML] High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia
Sixty-three children (1–14 years of age) newly diagnosed with T-cell acute lymphoblastic
leukemia were treated from January 2001 to December 2014. Patient outcomes were …
leukemia were treated from January 2001 to December 2014. Patient outcomes were …
Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?
W Jastaniah, N Elimam, K Abdalla, TM Khattab… - …, 2015 - Taylor & Francis
Objectives We aimed to determine whether the addition of two extra intrathecal methotrexate
(ITM) doses during induction in acute lymphoblastic leukemia (ALL) patients eliminate the …
(ITM) doses during induction in acute lymphoblastic leukemia (ALL) patients eliminate the …
Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia
Objectives: Acute lymphoblastic leukemia (ALL) with CNS2 status predicts inferior outcome
and a high rate of CNS relapse, similar to overt CNS leukemia (CNS3). The purpose of this …
and a high rate of CNS relapse, similar to overt CNS leukemia (CNS3). The purpose of this …